Avery Collins Facebook ad: “This is how to support ADHD during menopause”

About this ad

Meta Ad Library ID

1496445562196365

Platforms

Facebook, Instagram, Audience Network, Messenger and Threads

Relaunches

0

How we count

Ad text

Estrogen drives ADHD symptoms. ADHD brains drive dopamine demand. That is the loop. Most women in their 50s have heard some version of this. What nobody explains is what is keeping the loop running. It is not your stress levels. Women with calm, well-managed lives are stuck in this exact loop. It is not your dose. Women on the same Vyvanse or Adderall prescription that used to work perfectly are stuck in this exact loop. It is not your HRT, though the loop disrupts estrogen uptake and then the disrupted uptake makes the loop worse. The mechanism keeping it running is the dopamine receptors' reduced capacity to catch the signal your stimulants release. When the receptors are damaged, which after 30 years of undiagnosed ADHD and 5 to 10 years of estrogen collapse most of them are, dopamine does not get caught and used the way it should. It gets released into the synapse and degraded without effect. And undelivered dopamine tells the body the brain is still starving, which keeps cortisol high, which keeps damaging receptors further. The loop does not have an exit as long as the receptors stay damaged. Treating the symptoms directly with stimulants, with HRT, with focus supplements, is treating the dopamine supply and not the reception. It is addressing the signal rather than the machinery that is supposed to receive it. Which is why it helps a little, or helps for a while, and then stops being enough. I specialise in neuroendocrine function in women. I have been in practice for 14 years. This is the piece I was missing for most of them. The stimulant advice was not wrong. Dopamine absolutely drives ADHD symptom control. The prefrontal cortex has more dopamine receptors than almost anywhere else in the brain, which is why focus is the first thing to go and the last thing to respond. When dopamine stays available it signals the reward and attention systems to fire. It stabilises executive function. It lowers the mental noise that exhausts you. Emotional regulation holds. Sleep normalises, which protects cortisol levels the next day, creating a cycle that functions. What I was missing was why dopamine was not landing in the first place. The dopamine receptors are responsible for catching the signal and converting it into function. When they are healthy and plentiful, that process runs efficiently. Your Vyvanse or Adderall releases dopamine, the receptors catch it, focus returns, the fog lifts. When estrogen is present, that process is protected. Estrogen increases receptor density, slows dopamine degradation, and shields receptors from cortisol damage. But here is what happens after 30, 40 years of undiagnosed ADHD and then perimenopause arriving on top of it. Every year your brain has been running dopamine-deficient. Every year of chronic stress from masking symptoms nobody diagnosed. Every cortisol spike from decades of being told you were lazy when you were actually struggling. The receptors are not destroyed. They are not gone. They are damaged. They are handling less than they once did, and when receptors are damaged and the system is triaging, it prioritises the most urgent functions first. Keeping you upright, alert, reactive to danger. Running sustained focus and working memory is important but not immediately critical. So the system deprioritises it, and the dopamine your stimulants release starts washing through without sticking. The stimulants my patients were taking were attempting to flood a receptor system that was too damaged to catch what was already being released. It is like pouring water into a cracked cup. You can manage the symptom slightly. You cannot resolve it. The receptors are also the primary mechanism for emotional regulation and task initiation. When they are damaged and triaging, those functions get deprioritized for the same reason. The brain focuses on what keeps you alive, and starting the laundry is not that. The task sits there, along with the unopened mail and the half-read book and the work email you meant to answer three hours ago, while the brain handles everything it considers more urgent. Women could take their Vyvanse or Adderall exactly as prescribed and watch their focus evaporate by noon, because the receptors responsible for holding that focus were too damaged to do the job. HRT could produce some initial result and then stall. Meditation could improve everything except the executive function. Not because those things do not work. Because the machinery that completes the process was never addressed. Once I understood this I went back into the supplement literature properly. I had been recommending magnesium and ashwagandha to patients for years and I knew the research on both was legitimate when used correctly. But what I had not looked closely at was what most formulas were actually delivering once you looked past the label. I reviewed more than 30 focus and cognitive supplements over several months. Most failed immediately. The ashwagandha in the majority of American cognitive products is generic root powder or a low-potency extract. It is in every wellness product on the shelf now, which creates the impression that ashwagandha is ashwagandha. It is not. The only ashwagandha extract with published clinical data on cortisol reduction is KSM-66, standardised to the exact bioactive concentration used in the trials. A label that says ashwagandha is not the same thing as KSM-66 at 300mg. Most of what my patients had been taking for years was a fundamentally different product from the one in the research. The magnesium situation is worse. Magnesium is one of the most common supplements women take after 40, and most women are taking it in the form their body absorbs least. Magnesium oxide, the cheapest and most widely used form, has roughly 4% bioavailability. Which means 96% of what is in the bottle does not reach the brain or the nervous system. Magnesium glycinate, the form used in the research on cognitive function and neurotransmitter support, absorbs at a dramatically higher rate. Most formulas use oxide because it costs less and looks identical on a label. And even the right ashwagandha and the right magnesium only reach part of what is failing in a 50-year-old ADHD brain. The dopamine piece is where the real gap sits. For decades, saffron extract has been studied for mood and cognitive support, but the early research used raw saffron in inconsistent doses and the results were all over the place. Then the standardised Affron extract was developed specifically for clinical research, delivering the exact active compounds at the exact concentration the trials required. In published research, standardised Affron at 30mg produced measurable improvements in reward responsiveness and cognitive function. Generic saffron does not replicate those results because it is not delivering the same compounds at the same concentration. The receptors stay damaged when cortisol stays elevated. That accumulated cortisol is part of what degrades the machinery in the first place. A brain soaking in unresolved cortisol cannot efficiently catch dopamine or regulate emotion the way it is designed to. KSM-66 at the full 300mg clinical dose brings cortisol back into range and protects receptors from further damage. In a published study over 60 days, patients showed a 63.2% reduction in cortisol levels alongside measurable improvements in perceived stress, sleep quality, and cognitive function. When you help the brain clear its cortisol backlog, the receptors function better across every process they handle, including catching dopamine and regulating emotion. Affron restores the reception. KSM-66 protects what was just restored. The third piece is the neurotransmitter co-factors your body stopped producing efficiently after 40. Most women cannot feel this directly. There are no obvious symptoms. But it is what makes the whole system sluggish across all of its functions. Magnesium glycinate, B6, zinc, and D3 at properly dosed amounts address this specific gap. These are the raw materials the brain uses to manufacture and move neurotransmitters. Without them, the enzymatic machinery slows. With them at clinical doses, synthesis and signalling run the way they are designed to. In combination with Affron and KSM-66, the three pieces work together in a way that none of them accomplish alone. Three specific things. Standardised Affron saffron at the 30mg clinical trial dose. KSM-66 ashwagandha at 300mg for cortisol and receptor protection. Magnesium glycinate, B6, zinc and D3 at clinical amounts, not label dust. Not one of the 30-plus formulas I reviewed had all of these at the right grades and doses together. Most had one ingredient. Several had two at doses too low to produce a measurable effect. Some listed the right ingredients but used proprietary blends that made it impossible to verify what was actually inside. One formula matched everything I had been looking for. Before I say which one, I want to be transparent about something. I am not affiliated with any supplement company. I do not receive compensation for recommending products. What I do is research, and I share what the research points to because I spent too many years watching women fail on approaches that were missing the fundamental piece. That is the only reason I am writing this. The formula was Steady Base from Corvela Labs. Standardised Affron saffron at the exact 30mg dose used in the published trials. KSM-66 ashwagandha at the 300mg clinical dose, verified by third-party testing rather than self-declared. Magnesium glycinate, not oxide, at clinical amount. B6, zinc and D3 at doses matching the research, not token quantities added to pad the label. I reviewed it for several weeks before I recommended it to a single patient. I cross-referenced the third-party verification. I confirmed each ingredient was standardised and dosed to match what the clinical research actually used. I am not someone who recommends things lightly, and I was not going to hand this to patients who had already been failed repeatedly by things that overpromised. When I was satisfied that what was on the label matched what was actually inside, I started recommending it to the patients I had been unable to help with anything else. The results I saw were consistent enough across enough patients that I feel obligated to share this publicly. Most of these women came in expecting one specific thing. Their stimulants to start working again. That was not what happened first, which surprised almost all of them. Week 1, most women reported the same thing first. Not the focus. The noise. The constant mental chatter that had been running since perimenopause started, keeping them awake at night, exhausting them through the day, started quieting. Sleep deepened. The overwhelm that hit every afternoon, the paralysis staring at simple tasks, became noticeably easier to push through. These are cortisol-driven symptoms and they responded first, because cortisol reduction is one of the first changes KSM-66 produces. Week 2 to 3, the executive function shifted. The tasks that had been sitting undone for weeks. The emails unanswered for days. The simple decisions, like what to make for dinner, that had been taking twenty minutes of paralysis. These changed quietly, and almost every patient heard about it from someone else before she noticed it herself. A husband asking why the house was suddenly organised. A daughter saying her mother sounded more like herself on the phone. The shift was happening and they were the last ones to see it. Week 4 to 6, the stimulants started landing again. Not a different high. Not a stronger effect. The same Vyvanse or Adderall dose that had been fading by noon for months was holding through the afternoon. Focus that had come and gone unpredictably was steadying. One patient, 54 years old, told me she got through an entire workday without checking the clock once. She said she had forgotten what that felt like. Week 8, the changes held. Not in abstract terms. In the specifics that had driven these women into my office in the first place. Focus holding through the full workday on the same dose that had been failing for months. Tasks starting without the twenty-minute negotiation. Word recall returning. Conversations finishing without losing the thread halfway through. Emotional regulation, the thing most of them had given up on, holding even through days that would have derailed them a year ago. Morning cortisol levels, which I had been measuring as part of baseline workups, had normalised in the majority of cases, which was the lab confirmation of what the women were already feeling. One patient I want to mention specifically because her results were the clearest illustration of everything I have described here. 52 years old. Late-diagnosed ADHD at 48. On Adderall for four years, effective for the first two, increasingly unreliable for the last two. She had been asking her psychiatrist for a dose increase at her next appointment because the 30mg extended-release was not holding past lunchtime. At week 8 on Steady Base, alongside her existing Adderall and her HRT, her focus was holding through 5pm. Her cortisol had normalised for the first time in the three years I had been measuring it. She cancelled the dose increase conversation. Eight weeks. From a woman who had been doing everything right for four years and watching her treatment slowly fail anyway. The only variable was the receptors finally having what they needed to function the way they were designed to. Her psychiatrist asked what she had changed at her next appointment. She told him everything. He wrote it down. I am sharing this because I keep seeing women doing everything asked of them and getting nowhere with the one thing that matters most to them. The ADHD is real. The menopause collapse is real. The inability to feel like yourself again through stimulants and hormones alone is real. Only solving the root cause, which is rebuilding what damaged your dopamine receptors in the first place, makes it possible to break free from this. What is also real is that the receptors driving all of those outcomes had never been addressed in a way that matched what the research actually supports. Standardised Affron saffron at the trial dose. KSM-66 at the full clinical amount. Magnesium glycinate, B6, zinc and D3 at proper doses. All four, verified, at the amounts that moved scores in actual studies. That is what the 50-year-old ADHD brain needs, and it is what most formulas on the market are not providing. thanks for reading EDIT: A number of people have asked for the specific product because I did not include it in the original post. https://corvelalabs.com/products/corvela-steady-base-capsules Steady Base from Corvela Labs. Not on Amazon, their site only. There are products with similar names using different formulations, so confirm you are on the Corvela Labs site specifically before ordering. The formula uses standardised Affron saffron at the clinical trial dose, KSM-66 ashwagandha at 300mg, and magnesium glycinate at clinical amount, third-party verified. This is the single most important thing to confirm before purchasing any ADHD support supplement. Most products on the market do not meet this standard. Only recommend trying it because of the 60 day money back guarantee. If you see no meaningful difference in 2 months, you can just ask for a refund, which I honestly think is a no-brainer for those dealing with ADHD symptoms that haven't responded to anything else.

Where the ad sends people

corvelalabs.com

This is how to support ADHD during menopause

Corvela Steady Base supports your brain's natural serotonin and dopamine production. Built on clinically studied Affron® saffron and KSM-66® Ashwagandha.